Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey and B Medical Systems.BURLINGTON, Mass., Nov. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2024 earnings which ended on September 30, 2024, on Tuesday, November 12, 2024, after the market closes.
BURLINGTON，馬薩諸塞州，2024年11月4日/PRNewswire/-- Azenta公司（納斯達克: AZTA）將於2024年11月12日星期二在市場收盤後公佈截至2024年9月30日的財政第四季度和全年2024業績。
The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday, November 12, 2024, at 4:30 p.m. Eastern Time. Analysts, investors and members of the media can access the live webcast via the Azenta website at . A replay will be available beginning at 8:30 a.m. ET on November 13, 2024.
公司將於同日，2024年11月12日，東部時間下午4:30舉行電話會議和現場網絡視頻直播，討論其財務業績。分析師，投資者和媒體代表可以通過Azenta網站訪問現場網絡直播。重播將從2024年11月13日上午8:30開始提供。
About Azenta Life Sciences
Azenta，Inc.（納斯達克：AZTA）是全球領先的提供生命科學解決方案的供應商，使有影響的突破和治療方法更快地上市。Azenta爲製藥、生物技術、學術和醫療保健等行業的頂尖機構提供全套可靠的冷鏈樣本管理解決方案和多組學服務。我們的全球團隊通過領先品牌進行產品和服務的交付和支持，其中包括GENEWIZ、FluidX、Ziath、4titude、Limfinity、Freezer Pro、Barkey和B Medical Systems。
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey and B Medical Systems.
Azenta公司（納斯達克：AZTA）是全球領先的生命科學解決方案提供商，能夠更快地將突破性的突破和治療方法推向市場。Azenta爲製藥、生物技術、學術和醫療衛生機構提供一整套可靠的冷鏈樣本管理解決方案和多組學服務，覆蓋領域包括藥物研發、臨床研究和先進細胞療法等等。我們的全球團隊通過我們領先行業的品牌，包括GENEWIZ、FluidX、Ziath、4titude、Limfinity、Freezer Pro、Barkey和b Medical Systems來提供並支持這些產品和服務。
Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit .
Azenta總部位於馬薩諸塞州伯靈頓市，在北美、歐洲和亞洲擁有業務。更多信息，請訪問網站 。
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial Planning & Analysis, and Investor Relations
[email protected]
投資者聯繫方式：
Yvonne Perron
財務規劃與分析副總裁以及投資者關係
[email protected]
Sherry Dinsmore
[email protected]
Sherry Dinsmore
[email protected]
SOURCE Azenta
源自Azenta
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎？
譯文內容由第三人軟體翻譯。
